CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
fluconazoledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001542
NCT00001542Phase 4Completed
CompareCT.gov

Fluconazole Prophylaxis of Thrush in AIDS

National Institute of Allergy and Infectious Diseases (NIAID)·interventional·Posted May 22, 2002·Updated Mar 4, 2008

In Brief

A Phase 4 clinical trial evaluating fluconazole for Acquired Immunodeficiency Syndrome and 2 related conditions. Completed, across 1 site.

Detailed Summary

This is a placebo-controlled trial of intermittent fluconazole prophylaxis (200 mg orally three times a week) in the prevention of thrush.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcquired Immunodeficiency Syndrome, Candidiasis, Oral Candidiasis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 22, 2002
Enrollment StartJul 1, 1996
Study CompletionNov 1, 2001
TodayJul 2, 2026
Posted 24.1 years ago

Interventions

fluconazoledrug